Positron emission tomography in chronic obstructive pulmonary disease

Hellenic Journal of Nuclear Medicine

Volumn 16, Issue 2, 2013, Pages 121-124

  Madsen, Poul Henning ^a   Hess, Søren ^b   Hiølund Carlsen, Poul Flemming ^b   Alavi, Abass ^c  

^a LILLEBAELT HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

COPD; Inflammation; PET; Pulmonary emphysema

Indexed keywords

ALPHA 1 ANTITRYPSIN; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; DIAGNOSTIC AGENT;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ASTHMA; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COCHRANE LIBRARY; COR PULMONALE; ECHOCARDIOGRAPHY; EMBASE; HEART FUNCTION; HUMAN; INFLAMMATION; LUNG FUNCTION; MEDICAL SUBJECT HEADINGS; MEDLINE; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PULMONARY HYPERTENSION; RISK FACTOR; SHORT SURVEY; SMOKING; SYSTEMATIC REVIEW; DIAGNOSTIC USE; IMAGE ENHANCEMENT; PROCEDURES; SCINTISCANNING; METHODOLOGY; REVIEW;

FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; POSITRON-EMISSION TOMOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOPHARMACEUTICALS;

EID: 84891688058     PISSN: 17905427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (46)

1. Global strategy for the diagnosis, management and prevention of COPD, Global initiative for chronic obstructive lung disease (GOLD) 2013. Available from: http://www.goldcopd.org/. Assessed 28 March 2013.
2. Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: A result of "overspill" of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010; 65: 930-6.
3. Karadag F, Karul AB, Cildag O et al. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung 2008; 186: 403-9.
4. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59(7): 574-80. (Pubitemid 38901515)
5. Oki M, Saka H, Kitagawa C. Transesophageal bronchoscopic ultrasound-guided fine-needle aspiration for diagnosis of peripheral lung cancer. Ann Thorac Surg 2011; 91(5): 1613-6.
6. Mac Manus MP, Ding Z, Hogg A et al. Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis. Int J Radiat Oncol Biol Phys 2011; 5: 1365-71.
7. Njiaju UO, Truica CI. Metastatic prostatic adenocarcinoma mimicking inflammatory breast carcinoma: a case report. Clin Breast Cancer 2010; 10(1): E3-5.
8. Schaeffler F, Kos S. Solitary pulmonary nodule. Praxis 2009; 98(19): 1097-100.
9. Mizugaki H, Shinagawa N, Kanegae K et al. Combining transbronchial biopsy using endobronchial ultrasonography with a guide sheath and positron emission tomography for the diagnosis of small peripheral pulmonary lesions. Lung Cancer 2010; 68(2): 211-5.
10. Naidu SS, Rohatgi S, Herrmann HC, Glaser R. Unprotected left main "kissing" stent implantation with a percutaneous ventricular assist device. J Invasive Cardiol 2004; 16(11): 683-4. (Pubitemid 39532125)
11. Sebro R, Aparici CM, Hernandez-Pampaloni M. FDG PET/CT evaluation of pathologically proven pulmonary lesions in an area of high endemic granulomatous disease. Ann Nucl Med 2013 [Epub ahead of print]
12. Ohno Y, Nishio M, Koyama H. Oxygen-enhanced MRI, thin-section MDCT, and perfusion SPECT/CT: comparison of clinical implications to patient care for lung volume reduction surgery. AJR Am J Roentgenol 2012; 199(4): 794-802.
13. Noël-Savina E, Leroyer C, Descourt R. Delayed noninvasive reduction of large bullae following thoracic irradiation. Clin Imaging 2012; 36(5): 609-11.
14. Kostakis ID, Tomos P, Cholidou KG et al. Pulmonary aspergilloma: a potential cause of false positive fluorodeoxyglucose positron emission tomography scan. Gen Thorac Cardiovasc Surg 2012; 60(8): 528-30.
15. Furukawa M, Oto T, Yamane M et al. Spontaneous regression of primary lung cancer arising from an emphysematous bulla. Ann Thorac Cardiovasc Surg 2011; 17(6): 577-9.
16. 18F-fluorodeoxyglucose uptake. Nihon Kokyuki Gakkai Zasshi 2009; 47(7): 575-80.
17. Shapiro M, Vidal C, Lipskar AM et al. Placental transmogrification of the lung presenting as emphysema and a lung mass. Ann Thorac Surg 2009; 87(2): 615-6.
18. Yamada M, Goto S, Koshika M et al. Micropapillary component in lung adenocarcinoma generated in emphysema. Kyobu Geka 2007; 60(7): 541-5.
19. 18F-FDG-PET/CT in a patient after talc pleurodesis. Lung Cancer 2007; 58(3): 418-21.
20. Aigelsreiter A, Pump A, Buchhäusl W et al. Successful antibiotic treatment of Borreliosis associated pseudolymphomatous systemic infiltrates. J Infect 2005; 51(4): e203-6. (Pubitemid 41683883)
21. Mattioli S, D'Ovidio F, Daddi N et al. Transthoracic endosonography for the intraoperative localization of lung nodules. Ann Thorac Surg 2005; 79(2): 443-9. (Pubitemid 40186534)
22. Suzuki T, Iio M, Ozawa Y et al. Regional pulmonary function in intra-emphysematous bulla and peri-emphysematous bulla. Kokyu To Junkan 1992; 3: 283-7.
23. Konishi J, Yamazaki K, Tsukamoto E et al. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 2003; 70(5): 500-6. (Pubitemid 37526733)
24. Hughes JM, Rhodes CG, Brudin LH et al. Contribution of the positron camera to studies of regional lung structure and function. Eur J Nucl Med 1987; 13 Suppl: S37-41. (Pubitemid 17111828)
25. Murata K, Itoh H, Senda M et al. Stripe sign in pulmonary perfusion scintigraphy: central pattern of pulmonary emphysema. Work in progress. Radiology 1986; 160(2): 337-40. (Pubitemid 16070636)
26. Senda M, Murata K, Itoh H et al. Quantitative evaluation of regional pulmonary ventilation using PET and nitrogen-13 gas. J Nucl Med 1986; 27(2): 268-73. (Pubitemid 17024873)
27. 13N PET as a vascular biomarker in chronic obstructive pulmonary disease. J Nucl Med 2010; 51(1): 57-65.
28. Kwee TC, Torigian DA, Alavi A. Nononcological applications of positron emission tomography for evaluation of the thorax. J Thorac Imaging 2012; 28: 25-39.
29. Maki DD, Gefter WB, Alavi A. Recent advances in pulmonary imaging. Chest 1999; 116(5): 1388-402. (Pubitemid 29535997)
30. Washko GR. The role and potential of imaging in COPD. Med Clin North Am 2012; 96(4): 729-43.
31. Lin FI, Foster CC, Hagge RJ, Shelton DK. Extensive FDG uptake in accessory muscles of respiration in a patient with shortness of breath. Clin Nucl Med 2009; 34(7): 428-30.
32. Duarte PS, Zhuang H, Machado C et al. Increased FDG uptake in the right cardiac chambers in a patient with pulmonary emphysema. Clin Nucl Med 2002; 27(8): 605-6. (Pubitemid 36372907)
33. Basu A, Alzeair A, Li A et al. Intercostal muscle contraction or rib bone marrow activity? Clin Nucl Med 2007; 32: 739-40.
34. Jones HA, Soler N. Quantification of pulmonary inflammation by positron emission tomography in chronic obstructive pulmonary disease: a new horizon in the era of biomarkers? Am J Respir Crit Care Med 2012; 186(11): 1071-3.
35. 18F]FDG) uptake as a marker of lung inflammation in chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2011; 183(1): A6449.
36. Sato Y, Murata K, Ito H et al. Positron emission CT and X-ray CT findings in chronic obstructive pulmonary diseases. Rinsho Hoshasen 1987; 32(8): 895-900.
37. Itoh H, Murata K, Senda M et al. A new imaging of pulmonary ventilation using nitrogen-13 and positron emission tomography (PET). Kokyu To Junkan 1987; 35(1): 21-9.
38. Subramanian DR, Jenkins L, Edgar Ret al. Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography. Am J Respir Crit Care Med 2012; 186(11): 1125-32.
39. 18F-FDG uptake by respiratory muscles on PET/CT correlate with chronic obstructive pulmonary disease? J Nucl Med Technol 2011; 39(4): 252-7.
40. 18F-FDG PET pilot study. J Nucl Med 2010; 51(9): 1357-60.
41. Aydin A, Hickeson M, Yu JQ et al. Demonstration of excessive metabolic activity of thoracic and abdominal muscles on FDGPET in patients with chronic obstructive pulmonary disease. Clin Nucl Med 2005; 30(3): 159-64. (Pubitemid 40270962)
42. 18F-FDG-PET using computer-assisted analysis of diagnostic chest CT. Hell J Nucl Med 2013; 16(1): 12-8.
43. Basu S, Alzeair S, Li G et al. Etiopathologies associated with intercostals muscle hypermetabolism and prominent right ventricle visualization on 2-Deoxy-2[F-18] fluoro-D-glukosepositron emission tomography: Significance of an incidental finding and in the setting on a known pulmonary disease. Mol Imaging Biol 2007; 9: 333-9.
44. Jones HA, Marino PS, Shakur BH, Morrell NW. In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J 2003; 21: 567-73. (Pubitemid 36432506)
45. Grynberg A, Demaison L. Fatty acid oxidation in the heart. J Cardiovasc Pharmacol 1996; 28: S11-7. (Pubitemid 26314973)
46. Basu S, Kwee TC, Torigian D et al. Suboptimal and inadequate quantification: an alarming crisis in medical applications of PET. Eur J Nucl Med Mol Imaging 2011; 38: 1381-2.